You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

genetic aberration

Showing 1 - 25 of 7,390
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Clinical Utility of Oncomine Precision Assay Within Exactis

Recruiting
  • NSCLC
    • Moncton, New Brunswick, Canada
    • +6 more
    Dec 9, 2022

    A Taiwanese Oncogenetic Panel and Integrated Clinical Data

    Recruiting
    • Thyroid Cancer
    • A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Advanced Thyroid Cancer Patients
    • Kaohsiung, Taiwan
    • +7 more
    Sep 12, 2022

    MiT Family Translocation Renal Cell Carcinomas (IMCOR)

    Not yet recruiting
    • Renal Carcinoma
    • Data collection
    • Bordeaux, France
    • +3 more
    Jul 8, 2022

    Gastric Adenocarcinoma Trial in Worldwide (Derazantinib, Derazantinib-paclitaxel-ramucirumab, Derazantinib-atezolizumab)

    Completed
    • Gastric Adenocarcinoma
    • Orlando, Florida
    • +80 more
    Jan 13, 2023

    Urothelial Carcinoma Trial in Worldwide (Derazantinib dose level 1 (300mg once daily) monotherapy, Derazantinib various dose

    Completed
    • Urothelial Carcinoma
    • Derazantinib dose level 1 (300mg once daily) monotherapy
    • +4 more
    • Newnan, Georgia
    • +65 more
    Oct 19, 2022

    Precursor Cell Lymphoblastic Leukemia Trial in Germany (Inotuzumab ozogamicin)

    Recruiting
    • Precursor Cell Lymphoblastic Leukemia
    • Inotuzumab ozogamicin
    • Augsburg, Germany
    • +13 more
    Oct 31, 2022

    Infertility, Intellectual Disability, Malformation Trial (Optical Genome Mapping (Bionano®), Longread sequencing (Nanopore®))

    Not yet recruiting
    • Infertility
    • +2 more
    • Optical Genome Mapping (Bionano®)
    • Longread sequencing (Nanopore®)
    • (no location specified)
    Mar 11, 2022

    Constitutional Genomic Variants inPostnatal Cohort

    Recruiting
    • Developmental Disability
    • +5 more
    • Standard of care genetic testing group
    • Atlanta, Georgia
    • +7 more
    Mar 15, 2022

    Glioblastoma Multiforme Trial in Ulm (Surgery)

    Recruiting
    • Glioblastoma Multiforme
    • Surgery
    • Ulm, Germany
      Department of Neurosurgery
    Apr 30, 2021

    Central and Peripheral Wavefront Aberration Profile in Pediatric

    Not yet recruiting
    • Myopia
    • Intervention
    • Houston, Texas
      University of Houston College of Optometry - J. Armistead Bldg R
    Oct 9, 2023

    Solid Tumor, Hematological Malignancy Trial in Bayonne, Bordeaux, Pau (Newly obtained biopsy and Blood samples collection)

    Recruiting
    • Solid Tumor
    • Hematological Malignancy
    • Newly obtained biopsy and Blood samples collection
    • Bayonne, France
    • +5 more
    Feb 1, 2022

    MDS Trial in Innsbruck (Next Generation Sequencing, Tumorimmunological examinations - multiplex assays/quantitative polymerase

    Recruiting
    • Myelodysplastic Syndromes
    • Next Generation Sequencing
    • +5 more
    • Innsbruck, Tyrol, Austria
      Medical University of Innsbruck
    Apr 6, 2022

    Tumors Trial (ABN401)

    Not yet recruiting
    • Neoplasms
    • (no location specified)
    May 21, 2023

    Oesophageal Carcinoma Trial in Australia (APR-246)

    Terminated
    • Oesophageal Carcinoma
    • Clayton, Victoria, Australia
    • +4 more
    Dec 10, 2021

    Nsclc, EGFR Activating Mutation, EGF-R Positive NSCLC Trial in Hong Kong (Pembrolizumab, Lenvatinib, Pemetrexed)

    Recruiting
    • Nsclc
    • +5 more
    • Hong Kong, Hong Kong
      Queen Mary Hospital
    Nov 25, 2021

    Prostatic Hyperplasia Trial in Banha (Chromax, Sildosin Group, Placebo Group)

    Recruiting
    • Prostatic Hyperplasia
    • Banhā, Kalubyia, Egypt
      Banha University Hospitals
    Nov 9, 2022

    Advanced Pancreatic Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 Trial in

    Recruiting
    • Advanced Pancreatic Carcinoma
    • +27 more
    • Gainesville, Florida
    • +3 more
    Jan 3, 2023

    Myopia, Progressive Trial in Shenyang (0.01% atropine eye drop)

    Not yet recruiting
    • Myopia, Progressive
    • 0.01% atropine eye drop
    • Shenyang, Liaoning, China
      He Eye Hospital
    Oct 2, 2023

    Salivary Gland Cancer, Metastatic, Advanced Trial in Toronto (Selinexor, EGFR or HER2 Inhibitor, FGFR Inhibitor)

    Recruiting
    • Salivary Gland Cancer
    • +3 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Feb 18, 2022

    Myopia Trial in Tianjin (Orthokeratology with aspheric wide inversion zone design in the optical zone, Orthokeratology with

    Completed
    • Myopia
    • Orthokeratology with aspheric wide inversion zone design in the optical zone
    • Orthokeratology with traditional spherical design in the optical zone
    • Tianjin, China
      Tianjin Eye Hospital
    Jul 14, 2023

    Low Grade Glioma (LGG) of Brain With BRAF Aberration, High Grade Glioma (HGG) of the Brain With BRAF Aberration, Low Grade

    Recruiting
    • Low Grade Glioma (LGG) of Brain With BRAF Aberration
    • +2 more
    • Phoenix, Arizona
    • +12 more
    Apr 7, 2022

    Pseudophakia Trial in Houston (Visual Acuity, Biometric Data Collection, Patient Questionnaire)

    Completed
    • Pseudophakia
    • Visual Acuity
    • +2 more
    • Houston, Texas
      Berkeley Eye Center
    Nov 7, 2022

    Prostate Cancer Trial in Vancouver, Toronto (Apalutamide 60mg Tab, Abiraterone Acetate 250mg, Prednisone 5mg Tab)

    Recruiting
    • Prostate Cancer
    • Apalutamide 60mg Tab
    • +5 more
    • Vancouver, British Columbia, Canada
    • +1 more
    May 25, 2022

    Solid Tumor Trial in Italy, United States (Derazantinib low dose range, Derazantinib middle dose range, Derazantinib high dose

    Completed
    Has Results
    • Solid Tumor
    • Derazantinib low dose range
    • +3 more
    • Scottsdale, Arizona
    • +11 more
    Mar 7, 2022

    Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +49 more
    • Birmingham, Alabama
    • +1429 more
    Aug 17, 2022